Clin2
NCT07328542Possibly a fitNot yet recruiting

Blood pressure monitoring study in men with low testosterone

Hypogonadism, Male

Treatments studied

Part of Hormones & metabolism clinical trials.

This study examines how testosterone therapy affects blood pressure in men with low testosterone. It uses a 24-hour blood pressure monitor to track changes over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
144 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • Men aged 18 to 75 years old.
  • Diagnosed with low testosterone (primary or hypogonadotropic hypogonadism).
  • Not currently on testosterone therapy or have stopped treatment for at least 45 days.
  • Office blood pressure less than 140/90 mmHg.
  • Stable doses of any blood pressure or steroid medications for at least 4 weeks.
  • No history of prostate or breast cancer, blood clots, or recent major health events.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07278362Not yet recruiting· Phase 4
Testosterone therapy for men with low-risk prostate cancer on active surveillance

This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are not receiving active treatment. You may be eligible if you have confirmed low testosterone and are being monitored without intervention.

Miami, Florida
NCT06689085Recruiting· Phase 3
Testosterone replacement study for adolescent boys with low testosterone

This trial tests a testosterone injection (XYOSTED) to see if it's safe and effective for replacing testosterone in teenage boys who have low levels due to a known medical condition. It lasts 52 weeks, with an optional 2-year follow-up.

Los Angeles, California
NCT05249634Recruiting· Phase 2
Testosterone treatment study for men with chronic kidney disease

This Phase 2 study tests whether testosterone therapy can help men with chronic kidney disease who have low testosterone and related symptoms. It looks to see if treatment is safe and beneficial, while carefully checking heart, blood, prostate, and clotting risks.

St Louis, Missouri
NCT07752511Not yet recruiting
Stigma, identity, and quality of life in male hypogonadism

This study looks at how men with low testosterone (hypogonadism) feel about stigma, their sense of self, and their quality of life. It aims to understand these experiences better so that care can be improved.

Bingoel
NCT07761546Enrolling by invitation
Ai-test: microbiome nutrition for low testosterone

This study tests whether a special diet can improve symptoms of low testosterone in men. It is intended to help men with certain symptoms like a low sex drive or trouble having erections and whose blood tests show low to borderline testosterone levels.

Aydin
NCT01894308Not yet recruiting· Phase 2
Testosterone skin patch dose study in men with low testosterone

This Phase 2 trial tests different doses of a testosterone skin patch to see which works best and is absorbed safely. It may help men with low morning testosterone who can meet study requirements like non-smoking and multiple blood draws.

London

Hear when a new Hypogonadism, Male trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.